“alnylam-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
Regeneron: It’s Still Wait Until 2017 For Big Heart Drug Study 11/17/16 New York
With New Data, Medicines Co. Takes Long-Lasting Heart Drug to Phase 3 11/15/16 New York
Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More 10/07/16 National
Intellia Execs Talk CRISPR’s Path Forward at Xconomy’s Oct. 20 Event 10/06/16 Boston
Alnylam Scraps RNAi Drug After Safety Problems, Shares Plunge 10/05/16 Boston
Taking Aim at Alexion, Ra Pharma Heads to IPO Queue 10/03/16 Boston
Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More 09/30/16 National
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More 09/23/16 National
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Alnylam Advances RNAi Drug Results After Two Years of Treatment 07/01/16 Boston
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug 06/27/16 San Diego
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
East Coast Biotech Roundup: Homology, Biogen, Intellia & More 05/05/16 Boston
East Coast Biotech Roundup: Sarepta, Nico, Ironwood & More 04/28/16 Boston
CRISPR Developer Intellia Deals With Regeneron, Jumps Into IPO Queue 04/11/16 Boston
Making the Price Right: Ideas To Change Drug Costs Gain Momentum 04/05/16 National
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
Grail’s Discount, Pfizergan & Pricing Plans: Notes from the JPM Vortex 01/15/16 National
At Hematological Meeting, More Than Just Biotech Data Runs Blood Red 12/08/15 National
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Idea Behind Warp Drive’s New Cancer Attack Was Hiding In Plain Sight 11/10/15 Boston
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
Verastem Sinks as Mesothelioma Study Halted For Futility 09/28/15 Boston
Celgene Cozies up to Nurix With $150M Drug Development Deal 09/16/15 San Francisco
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
Page 1 of 10 next page »